Biocardia Stock Market Value

BCDA
 Stock
  

USD 1.49  0.03  2.05%   

Biocardia's market value is the price at which a share of Biocardia stock trades on a public exchange. It measures the collective expectations of Biocardia investors about the entity's future performance. With this module, you can estimate the performance of a buy and hold strategy of Biocardia and determine expected loss or profit from investing in Biocardia over a given investment horizon. Continue to Biocardia Hype Analysis, Biocardia Correlation, Biocardia Valuation, Biocardia Volatility, as well as analyze Biocardia Alpha and Beta and Biocardia Performance.
Symbol
Backtest


Is Biocardia's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biocardia. If investors know Biocardia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biocardia listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
25.3 M
Quarterly Revenue Growth YOY
0.3
Return On Assets
-0.45
Return On Equity
-1.0
The market value of Biocardia is measured differently than its book value, which is the value of Biocardia that is recorded on the company's balance sheet. Investors also form their own opinion of Biocardia's value that differs from its market value or its book value, called intrinsic value, which is Biocardia's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biocardia's market value can be influenced by many factors that don't directly affect Biocardia's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biocardia's value and its price as these two are different measures arrived at by different means. Investors typically determine Biocardia value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biocardia's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Biocardia 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Biocardia's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Biocardia.
0.00
06/10/2021
No Change 0.00  0.0 
In 1 year and 26 days
07/05/2022
0.00
If you would invest  0.00  in Biocardia on June 10, 2021 and sell it all today you would earn a total of 0.00 from holding Biocardia or generate 0.0% return on investment in Biocardia over 390 days. Biocardia is related to or competes with American Express. BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for car...More

Biocardia Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Biocardia's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Biocardia upside and downside potential and time the market with a certain degree of confidence.

Biocardia Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Biocardia's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Biocardia's standard deviation. In reality, there are many statistical measures that can use Biocardia historical prices to predict the future Biocardia's volatility.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Biocardia's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Biocardia in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.081.516.78
Details
Intrinsic
Valuation
LowReal ValueHigh
0.183.668.93
Details
Naive
Forecast
LowNext ValueHigh
0.0308411.546.81
Details
3 Analysts
Consensus
LowTarget PriceHigh
7.0010.3315.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Biocardia. Your research has to be compared to or analyzed against Biocardia's peers to derive any actionable benefits. When done correctly, Biocardia's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Biocardia.

Biocardia Backtested Returns

Biocardia secures Sharpe Ratio (or Efficiency) of -0.0768, which signifies that the company had -0.0768% of return per unit of risk over the last 3 months. Macroaxis standpoint towards foreseeing the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Biocardia exposes twenty-eight different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to confirm Biocardia mean deviation of 3.73, and Risk Adjusted Performance of (0.11) to double-check the risk estimate we provide.
The firm shows a Beta (market volatility) of 1.0167, which signifies a somewhat significant risk relative to the market. Let's try to break down what Biocardia's beta means in this case. Biocardia returns are very sensitive to returns on the market. As the market goes up or down, Biocardia is expected to follow. Even though it is essential to pay attention to Biocardia historical returns, it is always good to be careful when utilizing equity current trending patterns. Our philosophy towards foreseeing any stock's future performance is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. Biocardia exposes twenty-eight different technical indicators, which can help you to evaluate its performance. Biocardia has an expected return of -0.4%. Please be advised to confirm Biocardia maximum drawdown, semi variance, and the relationship between the sortino ratio and potential upside to decide if Biocardia performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.49  

Average predictability

Biocardia has average predictability. Overlapping area represents the amount of predictability between Biocardia time series from 10th of June 2021 to 22nd of December 2021 and 22nd of December 2021 to 5th of July 2022. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Biocardia price movement. The serial correlation of 0.49 indicates that about 49.0% of current Biocardia price fluctuation can be explain by its past prices.
Correlation Coefficient0.49
Spearman Rank Test0.52
Residual Average0.0
Price Variance0.1

Biocardia lagged returns against current returns

Autocorrelation, which is Biocardia stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Biocardia's stock expected returns. We can calculate the autocorrelation of Biocardia returns to help us make a trade decision. For example, suppose you find that Biocardia stock has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the stock movement to match the lagging time series.
 Current and Lagged Values 
Share
      Timeline 

Biocardia regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Biocardia stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Biocardia stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Biocardia stock over time.
 Current vs Lagged Prices 
Share
      Timeline 

Biocardia Lagged Returns

When evaluating Biocardia's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Biocardia stock have on its future price. Biocardia autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Biocardia autocorrelation shows the relationship between Biocardia stock current value and its past values and can show if there is a momentum factor associated with investing in Biocardia.
 Regressed Prices 
Share
      Timeline 

Biocardia Investors Sentiment

The influence of Biocardia's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Biocardia. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Biocardia Implied Volatility

    
  921.41  
Biocardia's implied volatility exposes the market's sentiment of Biocardia stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Biocardia's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Biocardia stock will not fluctuate a lot when Biocardia's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Biocardia in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Biocardia's short interest history, or implied volatility extrapolated from Biocardia options trading.

Current Sentiment - BCDA

Biocardia Investor Sentiment

Most of Macroaxis users are currently bullish on Biocardia. What is your opinion about investing in Biocardia? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish

Pair Trading with Biocardia

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biocardia position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biocardia will appreciate offsetting losses from the drop in the long position's value.

Biocardia Pair Correlation

Correlation Analysis For Direct Indexing and Tax-loss Harvesting

The ability to find closely correlated positions to Biocardia could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biocardia when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biocardia - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biocardia to buy it.
The correlation of Biocardia is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biocardia moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biocardia moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biocardia can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Biocardia Hype Analysis, Biocardia Correlation, Biocardia Valuation, Biocardia Volatility, as well as analyze Biocardia Alpha and Beta and Biocardia Performance. Note that the Biocardia information on this page should be used as a complementary analysis to other Biocardia's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for Biocardia Stock analysis

When running Biocardia price analysis, check to measure Biocardia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biocardia is operating at the current time. Most of Biocardia's value examination focuses on studying past and present price action to predict the probability of Biocardia's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Biocardia's price. Additionally, you may evaluate how the addition of Biocardia to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Biocardia technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Biocardia technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Biocardia trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...